loading page

Transcatheter Valve-in-Valve Implantation Edwards Sapien XT in a Direct Flow Valve after Early Degeneration
  • +2
  • Bilge Duran Karaduman,
  • Hüseyin Ayhan,
  • Serkan Bulguroğlu,
  • Telat Keles,
  • Engin Bozkurt
Bilge Duran Karaduman
Atılım University, Faculty of Medicine, Department of Cardiology, Medicana International Ankara Hospital
Author Profile
Hüseyin Ayhan
Atılım University, Faculty of Medicine, Department of Cardiology, Medicana International Ankara Hospital
Author Profile
Serkan Bulguroğlu
Ankara Yıldırım Beyazıt University, Faculty of Medicine, Department of Cardiology, Ankara City Hospital
Author Profile
Telat Keles
Ankara Yıldırım Beyazıt University, Faculty of Medicine, Department of Cardiology, Ankara City Hospital
Author Profile
Engin Bozkurt
Medicana International Ankara Hospital, Department of Cardiology
Author Profile

Abstract

In recent years, the use of bioprosthetic valve (BPV) has increased significantly with both surgical aortic valve replacement (SAVR) and transcatheter aortic valve implantation (TAVI) due to reasons such as the advantage of not using anticoagulants. Nevertheless major disadvantage of all BPV is the risk of early structural valve deterioration, leading to valve dysfunction, and requires reoperation, which significantly increases the risk of mortality or major morbidity especially after SAVR. There are a limited number of TAV-in-TAV case reports due to TAVI BPV degeneration. In our knowledge this is the second report of TAV-in-TAV implantation wherein a previously implanted transfemoral 25-mm nonmetallic Direct Flow SVD valve treated with ViV TAVI via Edwards Sapien XT.

Peer review status:ACCEPTED

27 Apr 2020Submitted to Journal of Cardiac Surgery
28 Apr 2020Submission Checks Completed
28 Apr 2020Assigned to Editor
29 Apr 2020Reviewer(s) Assigned
17 Aug 2020Review(s) Completed, Editorial Evaluation Pending
24 Aug 2020Editorial Decision: Revise Minor
24 Aug 20201st Revision Received
26 Aug 2020Submission Checks Completed
26 Aug 2020Assigned to Editor
26 Aug 2020Review(s) Completed, Editorial Evaluation Pending
31 Aug 2020Editorial Decision: Accept